Trilateral Retinoblastoma: Incidence and Outcomes

Clinical trial NCT06367530 · RECRUITING

Trial details

NCT number: NCT06367530
Sponsor: Amsterdam UMC, location VUmc
Status: RECRUITING
Study type: OBSERVATIONAL

Trilateral Retinoblastoma Retinoblastoma

Start date: 2024-01-01
Primary completion: 2027-12-31
Enrollment: 4351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.